Brazil’s health regulator Anvisa announced on Wednesday the resumption of clinical Phase III trials for China’s Sinovac COVID-19 vaccine.
Anvisa on Monday suspended the trials of the Sinovac vaccine after the death of a volunteer that was registered as a suicide.
For more coronavirus news, visit our dedicated page.
The regulator said that it had not been informed of the cause of the volunteers’ death when it took the decision and was only provided with the details the following day by the Butantan biomedical center which is running the trials.
“After evaluating the new data presented by the sponsor... Anvisa understands that it has sufficient reasons to allow the resumption of vaccination,” the agency’s statement said.
“It is important to clarify that a suspension does not necessarily mean that the product under investigation does not offer quality, safety or efficacy,” Anvisa said.
Coronavirus: Brazil reports 10,554 COVID-19 cases, 128 deathsBrazil on Sunday reported 128 new COVID-19 deaths and 10,554 new coronavirus cases, according to official data.For more on coronavirus, visit our ... Coronavirus
Brazil’s Bolsonaro favors Trump win in US electionBrazil President Jair Bolsonaro on Wednesday refrained from commenting on a potential US election victor, but reiterated his support for Donald Trump, ... World News
Coronavirus: Brazil allows Johnson & Johnson’s to resume trial of COVID-19 vaccineBrazilian health regulator Anvisa has authorized resumption of a clinical trial of Johnson & Johnson’s experimental COVID-19 vaccine, according to a ... Coronavirus